The mechanism by which specific hormonal regulation of gene expression is attained in vivo is a paradox in that several of the steroid receptors activate the same DNA element in vitro. Despite their functional diversity, glucocorticoid, androgen, progesterone, and mineralocorticoid receptors (GR, AR, PR, MR) are structurally uniform and recognize the same consensus hormone response element (HRB). To elucidate how specific transcription is imposed, we are studying a complex enhancer of the mouse sex-limited protein (Slp) gene that is activated exclusively by androgens and not by glucocorticoids. Potent androgen induction requires both a consensus HRE and nonreceptor-binding elements present within a 120 base pair DNA fragment. In contrast to the strong response invoked by AR, GR can bind the HRE within the enhancer but cannot transactivate from that site. Thus specific transcriptional response to androgens, and lack of response to glucocorticoids, derives from selective protein-protein interactions that are determined by the context of the receptor binding site rather than by its distinct sequence. Our goal is to identify the accessory factors that impose this hormonal specificity. Strategies for isolation of these proteins and for functional proof of their significance benefit from the dual nature of specificity, which must as stringently prevent the action of some receptors as enhance the effectiveness of others. Specifically, we will: I) identify domains of AR and GR that confer differential response, by testing the ability of mutant receptors to activate specific and nonspecific enhancers in transfection; II) generate probes of protein-protein interaction by expressing these receptor domains in bacteria, and generate DNA probes by greater definition of nonreceptor protein-DNA interaction; III) isolate accessory factor cDNA clones from expression libraries by screening with both protein and DNA probes; W) prove the functional significance of these factors by their ability to alter differential responsiveness of the specific enhancer in distinct host cells, and demonstrate physical interaction of these factors in ternary complexes with the enhancer and receptor. These experiments will be complemented by assays in hormonally- treated and transgenic mice to validate the physiological significance of the nonreceptor factors in regulation. Steroid-specific transcription is implicit in normal development, homeostasis, and reproduction. Understanding the mechanism by which specific hormone response is elicited from nonspecific receptor binding sites may allow novel insights for combatting hormone-dependent tumors, such as those of the breast and prostate. For prostate cancer particularly, identification of cell-specific factors required for androgen action may have crucial value for future prognosis and therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM031546-13
Application #
2176175
Study Section
Endocrinology Study Section (END)
Project Start
1983-01-01
Project End
1998-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
13
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Genetics
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ning, Y M; Robins, D M (1999) AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene. J Biol Chem 274:30624-30
Scheller, A; Hughes, E; Golden, K L et al. (1998) Multiple receptor domains interact to permit, or restrict, androgen-specific gene activation. J Biol Chem 273:24216-22
Scarlett, C O; Scheller, A; Thompson, E et al. (1997) Involvement of an octamer-like sequence within a crucial region of the androgen-dependent Slp enhancer. DNA Cell Biol 16:45-57
Nelson, S A; Robins, D M (1997) Regulatory capacity of an androgen-specific enhancer of the mouse Slp gene in transgenic mice. Mol Cell Endocrinol 133:89-97
Nelson, S A; Robins, D M (1997) Two distinct mechanisms elicit androgen-dependent expression of the mouse sex-limited protein gene. Mol Endocrinol 11:460-9
Burgos-Trinidad, M; Youngblood, G L; Maroto, M R et al. (1997) Repression of cAMP-induced expression of the mouse P450 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) by androgens. Mol Endocrinol 11:87-96
Scarlett, C O; Robins, D M (1995) In vivo footprinting of an androgen-dependent enhancer reveals an accessory element integral to hormonal response. Mol Endocrinol 9:413-23
Adler, A J; Scheller, A; Robins, D M (1993) The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences. Mol Cell Biol 13:6326-35
Adler, A J; Danielsen, M; Robins, D M (1992) Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc Natl Acad Sci U S A 89:11660-3
Cox, B J; Robins, D M (1988) Tissue-specific variation in C4 and Slp gene regulation. Nucleic Acids Res 16:6857-70

Showing the most recent 10 out of 14 publications